CL has a Zacks Rank #3 (Hold), higher forward P/E ratio (22.74), unfavorable PEG ratio (4.10), and a Value grade of D, indicating it is overvalued relative to EYE and offers less attractive value for investors.
The article presents Colgate-Palmolive as an 'excellent choice' for dividend investors, highlights its ability to generate revenue growth despite macroeconomic challenges, and positions it favorably for passive income strategies. The Motley Fool also has a position in and recommends the stock.
The stock is featured as an undervalued dividend stock opportunity that is outperforming in 2026. Despite a recent 2.05% decline, it is presented as a buy recommendation for dividend investors seeking value.
Articles that tag CL but are mainly about other companies.
Positive Earnings ESP of +1.94% combined with Zacks Rank #3 (Hold) suggests favorable conditions for an earnings beat. Expected revenue growth of ~4% and EPS growth of 1.1% with a trailing four-quarter earnings surprise average of 3.2%.
Despite S&P 100 removal, the company demonstrates strong fundamentals with 63 years of consecutive dividend increases, healthy earnings growth projections (17% CAGR through 2028), stable recession-resistant business model, and reasonable valuation at 22x forward earnings. Removal was due to relative underperformance versus AI stocks, not business deterioration.
Colgate is enhancing operational efficiency through digital technologies, automation, and productivity initiatives to manage cost inflation. Its diversified portfolio across multiple price points and strong emerging market presence position it well for sustainable growth and competitive advantage.
While the company faces significant Q2 challenges with declining consumption and shipments, management has outlined a concrete recovery strategy with premium product focus, increased marketing, and targeted pricing. The stock trades at a premium valuation (21.63X forward P/E vs 18.44X industry average), and recovery is expected but cautioned as uneven and dependent on uncertain consumer demand trends.
Colgate is strengthening its Home Care business through innovation, premiumization, and focused brand support, with fabric softeners and surface cleaners showing strong performance. Strong brand equity and global distribution provide a solid platform for expansion.
Being removed from S&P 100 as part of routine rebalancing, no specific performance issues mentioned
Listed as key market player but no specific strategic developments or performance metrics mentioned in the article.
Demonstrating broad-based growth across emerging markets (mid-single digits), Europe, and Hill's Pet Nutrition through innovation, premiumization, and market-share gains. Strong performance in key markets like India, Brazil, Mexico, and China supports positive momentum.
Mentioned as a peer comparison showing 2.4% organic sales growth and 8% base-business EPS growth in Q2 2026, demonstrating relatively stronger performance than PG's expected growth trajectory, but no direct investment recommendation provided.
Mentioned as a comparable company successfully using productivity improvements while maintaining elevated advertising investment in the consumer staples sector, but no specific company-level analysis or outlook provided.
Active participant in the pet treats market with opportunities in dental chews and functional treats, benefiting from the fastest-growing immune support segment.
Positioned as a reliable, lower-risk dividend component with stable cash generation and strong balance sheet. Lower yield (2.4%) but steady dividend growth, with potential upside from premium product initiatives and improved U.S. advertising.
The article presents Colgate as an attractive buying opportunity during a modest pullback. The company's 64-year dividend increase streak, lower volatility profile compared to the S&P 500, strong free cash flow coverage of dividends, and strategic investments in AI and technology support a positive outlook for dividend-focused investors.
Strong YTD performance (+20.4%), reliable dividend history (63 consecutive years of increases), superior margins compared to peers (>20%), solid guidance for 2026 growth (2-6% net sales), and demonstrated resilience navigating industry challenges through brand strength and geographic diversification.
Chief Sustainability Officer selected as distinguished speaker faculty, demonstrating active engagement in global sustainability leadership and climate strategy.
Identified as a key player in the laundry detergents market, able to leverage its brand portfolio and distribution network in the growing market.
Mentioned as a larger competitor to Clorox with greater financial resources, representing competitive risk but not directly evaluated in the article.
Recommended as a defensive stock with 63 consecutive years of dividend increases, strong brand portfolio of essential consumer products, recent record quarterly sales, and 2.3% dividend yield, despite warnings about rising packaging and material costs.
Mentioned as a competitor to P&G with significantly lower advertising spend ($2.7B vs P&G's $9.2B), highlighting P&G's competitive advantage but not providing specific positive or negative commentary about Colgate itself.
Two years of flat stock performance with no visible catalysts; low switching costs in key product categories (Ajax cleaner, Palmolive dish soap) vulnerable to generic competition; insider selling with no offsetting purchases; trading at 23x earnings despite low-to-mid single-digit growth with limited valuation cushion.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
